Vorinostat Completed Phase 2 Trials for Stage IV Renal Cell Cancer / Renal Cell Carcinoma Recurrent Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00278395Vorinostat in Treating Patients With Kidney Cancer